Asparkam. Ntuziaka maka ojiji

Ka ụbọchị, na shelves nke pharmacies i nwere ike ịhụ a nnukwu ọnụ ọgụgụ nke ọgwụ ọjọọ na a dịgasị iche iche nke ngwaahịa iche-iche. Mbadamba, ointments, ọgwụ, creams, liniments, ntụ maka nkwadebe nke ihe ngwọta, suppositories, sprays na ndị ọzọ.

All ndị a iche nke ọgwụ ọjọọ eme ihe na-akwalite kacha adaba na ojiji nke ọgwụ ọjọọ na n'oge mmalite mmetụta dị mma.

Preparations bụ ugbu a ike iji gwọọ fọrọ nke nta ọrịa nile. Na nke ọ bụla, na ọgwụgwọ nke ọrịa na-enweghị iji ọgwụ ọjọọ eme na-adịghị emebiwo.

Akpan akpan ntị ga-akwụ ụgwọ dị otú ahụ ọgwụ ọjọọ eme ihe dị ka "Asparkam" ntụziaka ntuziaka nke na-enye ihe oru oma eji ya iji weghachi nke itule nke potassium na magnesium ke idem. Ọgwụ e ji mee nke ọma n'ihi na ejuputa a enweghị Chọpụta ọcha depụtara n'elu.

Active Efrata bụ potassium na magnesium aspartate. Abstract "Asparkam" na-agụnye ihe ọmụma banyere ihe ndị na-egosi, ojiji, ọgwụgwọ dose, mmetụta na na na mmekọrịta ndị ọzọ mbadamba.

Oge akara aka nke ọgwụ ọjọọ na-emepụta na ọnụnọ nke a dọkịta na kwesịrị ekwesị na-egosi.

Ọnụnọ nke hypokalemia ma ọ bụ hypomagnesemia set bụ a Agba mkpa maka oru nke ọgwụ "Asparkam". Ntuziaka maka ojiji, ke adianade do, enye ndị na-esonụ ndepụta egosi:

- ischemia nke obi muscle ;

- enweghị gbasara obi ọrụ;

- mebiri obi ọnụego.

Contraindications bụ:

- gbasara akụrụ odida (CRF na ARF);

- elu ọdịnaya nke potassium ke iyịp.

Ọ bụ uru na-arịba ama na ọgwụ ọgwụ adịghị mkpa maka imebi nke n'afọ iri na ụma na atrioventricular mgbochi. Ọzọkwa ọrụ bụ enweghị ezi uche mbadamba mgbe eji potassium-ịhapụ elekọta mmadụ (nke nwere ike na-eduga mmepe nke hyperkalemia). The ngwa nke n'aka na njikọ na loop diuretics (Lasix, furosemide), nke na-egosiputa a ọkpụrụkpụ ego nke potassium si ahụ mmadụ.

Nkwadebe "Asparkam" usoro nke ngwa bụ na-edeghị ede, advantageously arụpụtara ke mbadamba ụdị. Ọ na-eji ọgwụ ọjọọ n'ihi na otu onye - mbadamba nkume abụọ ugboro atọ n'ụbọchị. Dabere na nke ọrịa ọrịa ndị chọrọ ojiji nke mbadamba, oge nke ọgwụgwọ nwere ike ịdị iche iche, ma ọtụtụ mgbe na-atọ na anọ izu.

E wezụga na-emebu ka anyị nwee mbadamba, ọ bụ ike iji ihe ngwọta maka ọgwụ "Asparkam". Ntuziaka maka ojiji nke ọgwụ nwekwara a ndepụta mmetụta, tinyere ọgbụgbọ na erughị ala na afo (naanị mgbe eji mbadamba). Nke a pụrụ isi kwuo ya nwere ike ịzụlite mgbu na cholecystitis. Mbenata dose of n'ikuku na-ewe ndị dị otú ahụ n'obiọma. Igba ogwu n'akwara ọgwụ adịghị eme ka mmetụta. The imposition pụtara na ọnụnọ nke a onye hypersensitive ka onye nke ya mmiri.

Mere ọgwụ na-eji n'oge gbasara obi abnormalities?

Firstly, nke a bụ n'ihi na ike nke potassium ion mezie akwara conduction (na-eme ka eji ya mgbe arrhythmia). Nke abuo, a ala dose of potassium ion dilate na akwara arịa na-adịghị ewe obi ọnụego, nke na-ebelata ibu na obi muscle na ọbara ya ọkọnọ mma.

Nkwadebe "Asparkam" ntụziaka ntuziaka nke na-agụnye a nkọwa nke ya constituent-arụ ọrụ bekee (aspartate). N'ihi ya, gụnyere na a ndepụta nke nọ n'ọrụ ogige magnesium aspartate bụ a regulator nke DNA na RNA njikọ, na lipolysis stimulator na, ke adianade do, mma penetration nke potassium ion gafee cell akpụkpọ ahụ.